Related Experiment Video
Updated: Jul 16, 2026
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
Binocular treatment of amblyopia: current state and recent advances
Anna Sterkin1, Oren Yehezkel2,3
1Biomedical Strategy Ltd., Haifa.
Purpose Of Review:
To provide an overview of research from recent randomized clinical trials (RCTs) on novel binocular treatments for amblyopia, inherently designed to force binocular integration by simultaneous dichoptic stimulation. Second, to present an update on the most recent research.
Recent Findings:
In recent years, binocular treatments as either standalone or adjunct first-line therapies for amblyopia have been gaining acceptance, particularly for older patients and those who are either resistant to or noncompliant with traditional penalization therapy. The findings from a growing body of high-level clinical evidence are highlighted.
Summary:
Clinically significant improvements in visual acuity and stereopsis can be achieved with binocular therapy. Several of these therapies are commercially available and have consistently shown noninferiority over standard patching treatment or full-time refractive correction. The data suggest binocular treatments should be considered as standalone or adjunct first-line therapy. However, more research is necessary to support some reports of superiority and long-term stability of gains, and to establish specific clinical recommendations with consideration of patient's age and amblyopia etiology.
Insights
Novel binocular treatments for amblyopia, using simultaneous dichoptic stimulation, show significant improvements in visual acuity and stereopsis. These therapies are increasingly accepted as effective alternatives to traditional patching for amblyopia patients.
Area of Science:
- Ophthalmology
- Neuroscience
- Vision Science
Background:
- Amblyopia, or "lazy eye," affects visual development.
- Traditional treatments like patching are often difficult for patients.
- Novel approaches aim to improve binocular integration.
Purpose of the Study:
- Review recent randomized clinical trials (RCTs) of novel binocular treatments for amblyopia.
- Provide an update on the latest research in dichoptic stimulation therapies.
- Assess the efficacy and acceptance of these new treatments.
Main Methods:
- Analysis of recent randomized clinical trials (RCTs).
- Focus on therapies employing simultaneous dichoptic stimulation.
- Evaluation of clinical evidence for binocular integration treatments.
Main Results:
- Binocular treatments demonstrate clinically significant improvements in visual acuity and stereopsis.
- These therapies are gaining acceptance, especially for older or noncompliant patients.
- Evidence shows noninferiority compared to standard patching or refractive correction.
Conclusions:
- Binocular therapies are effective standalone or adjunct first-line treatments for amblyopia.
- Further research is needed to confirm superiority and long-term outcomes.
- Personalized recommendations considering age and etiology are necessary.
Related Concept Videos
01:25Glaucoma: Overview
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
01:23Ophthalmic Drug Delivery Systems